Stock ZHYBF ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhong Yuan Bio-Technology Holdings Limited

Equities

ZHYBF

KYG989A31097

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 15:40:31 26/04/2024 BST 		5-day change 1st Jan Change
5 USD 0.00% Intraday chart for Zhong Yuan Bio-Technology Holdings Limited -0.40% +146.31%
03-25 Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
2023 Zhong Yuan Bio-Technology Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI

Business Summary

Zhong Yuan Bio-Technology Holdings Ltd is an investment holding company principally engaged in the development and sale of health supplements. The Company operates its business through two segments. The Sales of Health Care Supplements segment is engaged in the development and sale of new drugs for neurological disorders, brain disease detection kits, the sale of plant-derived nervonic acid health supplements as well as others. The Company's main products are nervonic acid series supplements, marketed under the 'Muzhiyuan Neuro Enhancer' brand. The Technical Supporting Services segment is engaged in the provision of technical services.

Number of employees: 35

Sales per Business

USD in Million2022Weight2023Weight Delta
Health Care Supplements
89.6 %
2 77.3 % 1 89.6 % -17.23%
Technical Supporting Services
10.4 %
1 22.7 % 0 10.4 % -67.22%

Sales per region

USD in Million2022Weight2023Weight Delta
China
100.0 %
2 100.0 % 2 100.0 % -25.73%

Managers

Managers TitleAgeSince
Ting Ting Chang CEO
 Chief Executive Officer 34 02/05/17
Fung Ming Pang DFI
 Director of Finance/CFO 53 03/05/20
Xianyang Chen CTO
 Chief Tech/Sci/R&D Officer 40 31/12/15
Charles Sze IRC
 Investor Relations Contact - -
Yu Gao SAM
 Sales & Marketing - -

Members of the board

Members of the board TitleAgeSince
Chi Wai Tse BRD
 Director/Board Member 57 31/07/22
Ting Ting Chang CEO
 Chief Executive Officer 34 02/05/17
Fung Ming Pang DFI
 Director of Finance/CFO 53 03/05/20
Shuo Dong BRD
 Director/Board Member 60 31/07/22
Chinghai Ning BRD
 Director/Board Member 52 15/06/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,679,618 6,200,714 ( 35.07 %) 0 35.07 %

Shareholders

NameEquities%Valuation
Chang Yu
37.48 %
6,425,287 37.48 % 22 M $
Fung Ming Pang
18.83 %
3,228,506 18.83 % 11 M $
Ting Ting Chang
15.49 %
2,656,388 15.49 % 9 M $
Xian Yang Chen
12.39 %
2,125,111 12.39 % 7 M $

Company contact information

Zhong Yuan Bio-Technology Holdings Ltd.

Tesbury Centre 28 Queen's Road East

, Hong Kong

+

http://www.zhybiotech.com
address Zhong Yuan Bio-Technology Holdings Limited(ZHYBF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHONG YUAN BIO-TECHNOLOGY HOLDINGS LIMITED Stock Zhong Yuan Bio-Technology Holdings Limited
+146.31% 88.5M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ZHYBF Stock
  4. Company Zhong Yuan Bio-Technology Holdings Limited